| Literature DB >> 33643785 |
Paolo Armanetti1, Anastasia Chillà2, Francesca Margheri2, Alessio Biagioni2, Luca Menichetti1, Giancarlo Margheri3, Fulvio Ratto4, Sonia Centi4, Francesca Bianchini2, Mirko Severi5, Rita Traversi5, Daniele Bani6, Matteo Lulli2, Tommaso Del Rosso7, Alessandra Mocali2, Elisabetta Rovida2, Mario Del Rosso2, Gabriella Fibbi2, Anna Laurenzana2.
Abstract
Near infrared (NIR)-resonant gold nanoparticles (AuNPs) hold great promise in cancer diagnostics and treatment. However, translating the theranostic potential of AuNPs into clinical applications still remains a challenge due to the difficulty to improve the efficiency and specificity of tumor delivery in vivo as well as the clearance from liver and spleen to avoid off target toxicity. In this study, endothelial colony forming cells (ECFCs) are exploited as vehicles to deliver AuNPs to tumors. It is first demonstrated that ECFCs display a great capability to intake AuNPs without losing viability, and exert antitumor activity per se. Using a human melanoma xenograft mouse model, it is next demonstrated that AuNP-loaded ECFCs retain their capacity to migrate to tumor sites in vivo 1 day after injection and stay in the tumor mass for more than 1 week. In addition, it is demonstrated that ECFC-loaded AuNPs are efficiently cleared by the liver over time and do not elicit any sign of damage to healthy tissue.Entities:
Keywords: endothelial colony forming cells; gold nanoparticles; melanoma; nanomedicine; photoacoustic imaging
Year: 2020 PMID: 33643785 PMCID: PMC7887578 DOI: 10.1002/advs.202001175
Source DB: PubMed Journal: Adv Sci (Weinh) ISSN: 2198-3844 Impact factor: 16.806